A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumors. (2019)

First Author: Orienti I
Attributed to:  The role of p53/p73 family members in the cytotoxic response funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41419-019-1775-y

PubMed Identifier: 31332161

Publication URI: http://europepmc.org/abstract/MED/31332161

Type: Journal Article/Review

Volume: 10

Parent Publication: Cell death & disease

Issue: 7